Cronos (CRON) Other Non-Current Assets (2020 - 2025)
Cronos' (CRON) quarterly Other Non-Current Assets came in at $2.9 million in Q3 2025, up 2110.0% year-on-year from $130000.0 in Q3 2024, and up 2110.0% quarter-over-quarter from $130000.0 in Q3 2024.
Cronos (CRON) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Cronos' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $2.9 million for Q3 2025.
- On a quarterly basis, Other Non-Current Assets rose 2110.0% year-over-year to $2.9 million in Q3 2025; TTM through Sep 2025 was $2.9 million, a 2110.0% increase from a year earlier, with the FY2023 full-year figure at $45000.0, down 76.68% from the prior year.
- Other Non-Current Assets climbed to $2.9 million in Q3 2025 per CRON's latest filing, from $130000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $19.4 million in Q1 2024 and bottomed at $41000.0 in Q2 2024.
- The 5-year median for Other Non-Current Assets is $149000.0 (2022), against an average of $2.1 million.
- Across the five-year window, Other Non-Current Assets slumped 78.59% in 2021 and jumped 2110.0% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $100000.0 in 2021, then jumped by 93.0% to $193000.0 in 2022, then slumped by 76.68% to $45000.0 in 2023, then soared by 188.89% to $130000.0 in 2024, then soared by 2110.0% to $2.9 million in 2025.
- Per Business Quant, the three latest CRON Other Non-Current Assets figures stand at $2.9 million (Q3 2025), $130000.0 (Q3 2024), and $41000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.87 Mn |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 19.40 Mn |
| Dec 31, 2023 | 45,000.00 |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 193,000.00 |
| Sep 30, 2022 | 168,000.00 |
| Jun 30, 2022 | 89,000.00 |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 780,000.00 |
| Dec 31, 2020 | 467,000.00 |